Getting rid of caveolins: Phenotypes of caveolin-deficient animals

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1746, Issue 3, 2005, Pages 322-333

  Le Lay, Soazig ^a   Kurzchalia, Teymuras V ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

Caveolae; Caveolin; Knockout mouse; Metabolic disorder; Signaling

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CELL MARKER; MEMBRANE PROTEIN;

CAVEOLA; CELL MEMBRANE; FUNCTIONAL PROTEOMICS; GENE EXPRESSION; HUMAN; KNOCKOUT MOUSE; LIPIDOSIS; LUNG DISEASE; MUSCLE DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CAVEOLAE; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CYTOPLASMIC VESICLES; DISEASE MODELS, ANIMAL; FEMALE UROGENITAL DISEASES; LUNG DISEASES; MALE UROGENITAL DISEASES; MAMMARY GLANDS, ANIMAL; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; PHENOTYPE; VASCULAR DISEASES;

ANIMALIA;

EID: 29144505268     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2005.06.001     Document Type: Review

References (113)

1. T.V. Kurzchalia, P. Dupree, R.G. Parton, R. Kellner, H. Virta, M. Lehnert, and K. Simons VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles J. Cell Biol. 118 1992 1003 1014
2. K.G. Rothberg, J.E. Heuser, W.C. Donzell, Y.S. Ying, J.R. Glenney, and R.G. Anderson Caveolin, a protein component of caveolae membrane coats Cell 68 1992 673 682
3. J. Scheel, J. Srinivasan, U. Honnert, A. Henske, and T.V. Kurzchalia Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans Nat. Cell Biol. 1 1999 127 129
4. Y. Hagiwara, T. Sasaoka, K. Araishi, M. Imamura, H. Yorifuji, I. Nonaka, E. Ozawa, and T. Kikuchi Caveolin-3 deficiency causes muscle degeneration in mice Hum. Mol. Genet. 9 2000 3047 3054
5. F. Galbiati, J.A. Engelman, D. Volonte, X.L. Zhang, C. Minetti, M. Li, H. Hou Jr., B. Kneitz, W. Edelmann, and M.P. Lisanti Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities J. Biol. Chem. 276 2001 21425 21433
6. M. Drab, P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F.C. Luft, A. Schedl, H. Haller, and T.V. Kurzchalia Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 293 2001 2449 2452
7. B. Razani, J.A. Engelman, X.B. Wang, W. Schubert, X.L. Zhang, C.B. Marks, F. Macaluso, R.G. Russell, M. Li, R.G. Pestell, D. Di Vizio, H. Hou Jr., B. Kneitz, G. Lagaud, G.J. Christ, W. Edelmann, and M.P. Lisanti Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J. Biol. Chem. 276 2001 38121 38138
8. B. Razani, X.B. Wang, J.A. Engelman, M. Battista, G. Lagaud, X.L. Zhang, B. Kneitz, H. Hou Jr., G.J. Christ, W. Edelmann, and M.P. Lisanti Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae Mol. Cell. Biol. 22 2002 2329 2344
9. Y.Y. Zhao, Y. Liu, R.V. Stan, L. Fan, Y. Gu, N. Dalton, P.H. Chu, K. Peterson, J. Ross Jr., and K.R. Chien Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 11375 11380
10. G. Cao, G. Yang, T.L. Timme, T. Saika, L.D. Truong, T. Satoh, A. Goltsov, S.H. Park, T. Men, N. Kusaka, W. Tian, C. Ren, H. Wang, D. Kadmon, W.W. Cai, A.C. Chinault, T.B. Boone, A. Bradley, and T.C. Thompson Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis Am. J. Pathol. 162 2003 1241 1248
11. D.S. Park, A.W. Cohen, P.G. Frank, B. Razani, H. Lee, T.M. Williams, M. Chandra, J. Shirani, A.P. De Souza, B. Tang, L.A. Jelicks, S.M. Factor, L.M. Weiss, H.B. Tanowitz, and M.P. Lisanti Caveolin-1 null (-/-) mice show dramatic reductions in life span Biochemistry 42 2003 15124 15131
12. P.E. Scherer, R.Y. Lewis, D. Volonte, J.A. Engelman, F. Galbiati, J. Couet, D.S. Kohtz, E. van Donselaar, P. Peters, and M.P. Lisanti Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo J. Biol. Chem. 272 1997 29337 29346
13. R. Mora, V.L. Bonilha, A. Marmorstein, P.E. Scherer, D. Brown, M.P. Lisanti, and E. Rodriguez-Boulan Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1 J. Biol. Chem. 274 1999 25708 25717
14. I. Parolini, M. Sargiacomo, F. Galbiati, G. Rizzo, F. Grignani, J.A. Engelman, T. Okamoto, T. Ikezu, P.E. Scherer, R. Mora, E. Rodriguez-Boulan, C. Peschle, and M.P. Lisanti Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex J. Biol. Chem. 274 1999 25718 25725
15. G.E. Palade Fine structure of blood capillaries J. Appl. Physiol. 24 1953 1424 1436
16. J.E. Schnitzer, P. Oh, and D.P. McIntosh Role of GTP hydrolysis in fission of caveolae directly from plasma membranes Science 274 1996 239 242
17. R.G. Parton, and A.A. Richards Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms Traffic 4 2003 724 738
18. W. Schubert, P.G. Frank, B. Razani, D.S. Park, C.W. Chow, and M.P. Lisanti Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo J. Biol. Chem. 276 2001 48619 48622
19. W. Schubert, P.G. Frank, S.E. Woodman, H. Hyogo, D.E. Cohen, C.W. Chow, and M.P. Lisanti Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-name, restores normal microvascular permeability in Cav-1 null mice J. Biol. Chem. 277 2002 40091 40098
20. D.A. Brown, and E. London Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240 1997 1 7
21. S. Mayor, K.G. Rothberg, and F.R. Maxfield Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking Science 264 1994 1948 1951
22. R.G. Parton, B. Joggerst, and K. Simons Regulated internalization of caveolae J. Cell Biol. 127 1994 1199 1215
23. M.P. Lisanti, I.W. Caras, T. Gilbert, D. Hanzel, and E. Rodriguez-Boulan Vectorial apical delivery and slow endocytosis of a glycolipid-anchored fusion protein in transfected MDCK cells Proc. Natl. Acad. Sci. U. S. A. 87 1990 7419 7423
24. M.P. Lisanti, Z.L. Tang, and M. Sargiacomo Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae J. Cell Biol. 123 1993 595 604
25. F. Sotgia, B. Razani, G. Bonuccelli, W. Schubert, M. Battista, H. Lee, F. Capozza, A.L. Schubert, C. Minetti, J.T. Buckley, and M.P. Lisanti Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells Mol. Cell. Biol. 22 2002 3905 3926
26. L. Pelkmans, and A. Helenius Endocytosis via caveolae Traffic 3 2002 311 320
27. L. Pelkmans, J. Kartenbeck, and A. Helenius Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER Nat. Cell Biol. 3 2001 473 483
28. L. Pelkmans, D. Puntener, and A. Helenius Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae Science 296 2002 535 539
29. D.K. Sharma, A. Choudhury, R.D. Singh, C.L. Wheatley, D.L. Marks, and R.E. Pagano Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling J. Biol. Chem. 278 2003 7564 7572
30. E.M. Damm, L. Pelkmans, J. Kartenbeck, A. Mezzacasa, T. Kurzchalia, and A. Helenius Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae J. Cell Biol. 168 2005 477 488
31. M. Kirkham, A. Fujita, R. Chadda, S.J. Nixon, T.V. Kurzchalia, D.K. Sharma, R.E. Pagano, J.F. Hancock, S. Mayor, and R.G. Parton Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles J. Cell Biol. 168 2005 465 476
32. M. Murata, J. Peranen, R. Schreiner, F. Wieland, T.V. Kurzchalia, and K. Simons VIP21/caveolin is a cholesterol-binding protein Proc. Natl. Acad. Sci. U. S. A. 92 1995 10339 10343
33. C.J. Fielding, and P.E. Fielding Relationship between cholesterol trafficking and signaling in rafts and caveolae Biochim. Biophys. Acta 1610 2003 219 228
34. E. Ikonen, and R.G. Parton Caveolins and cellular cholesterol balance Traffic 1 2000 212 217
35. D. Hailstones, L.S. Sleer, R.G. Parton, and K.K. Stanley Regulation of caveolin and caveolae by cholesterol in MDCK cells J. Lipid Res. 39 1998 369 379
36. A. Bist, P.E. Fielding, and C.J. Fielding Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol Proc. Natl. Acad. Sci. U. S. A. 94 1997 10693 10698
37. C.J. Fielding, A. Bist, and P.E. Fielding Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers Proc. Natl. Acad. Sci. U. S. A. 94 1997 3753 3758
38. B. Razani, T.P. Combs, X.B. Wang, P.G. Frank, D.S. Park, R.G. Russell, M. Li, B. Tang, L.A. Jelicks, P.E. Scherer, and M.P. Lisanti Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities J. Biol. Chem. 277 2002 8635 8647
39. A.W. Cohen, W. Schubert, D.L. Brasaemle, P.E. Scherer, and M.P. Lisanti Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue Diabetes 54 2005 679 686
40. A.W. Cohen, B. Razani, X.B. Wang, T.P. Combs, T.M. Williams, P.E. Scherer, and M.P. Lisanti Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue Am. J. Physiol., Cell Physiol. 285 2003 C222 C235
41. M. Yamamoto, Y. Toya, C. Schwencke, M.P. Lisanti, M.G. Myers Jr., and Y. Ishikawa Caveolin is an activator of insulin receptor signaling J. Biol. Chem. 273 1998 26962 26968
42. F. Capozza, T.P. Combs, A.W. Cohen, Y.R. Cho, S.Y. Park, W. Schubert, T.M. Williams, D.L. Brasaemle, L.A. Jelicks, P.E. Scherer, J.K. Kim, and M.P. Lisanti Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle Am. J. Physiol., Cell Physiol. 288 2005 C1317 C1331
43. J. Oshikawa, K. Otsu, Y. Toya, T. Tsunematsu, R. Hankins, J. Kawabe, S. Minamisawa, S. Umemura, Y. Hagiwara, and Y. Ishikawa Insulin resistance in skeletal muscles of caveolin-3-null mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 12670 12675
44. T. Imamura, Y. Takata, T. Sasaoka, Y. Takada, H. Morioka, T. Haruta, T. Sawa, M. Iwanishi, Y.G. Hu, and Y. Suzuki Two naturally occurring mutations in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity J. Biol. Chem. 269 1994 31019 31027
45. M. Iwanishi, T. Haruta, Y. Takata, O. Ishibashi, T. Sasaoka, K. Egawa, T. Imamura, K. Naitou, T. Itazu, and M. Kobayashi A mutation (Trp1193-(Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance Diabetologia 36 1993 414 422
46. D.E. Moller, A. Yokota, F. Ginsberg-Fellner, and J.S. Flier Functional properties of a naturally occurring Trp1200-Ser1200 mutation of the insulin receptor Mol. Endocrinol. 4 1990 1183 1191
47. D.E. Moller, A. Yokota, M.F. White, A.G. Pazianos, and J.S. Flier A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance J. Biol. Chem. 265 1990 14979 14985
48. T. Fujimoto, H. Kogo, K. Ishiguro, K. Tauchi, and R. Nomura Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell J. Cell Biol. 152 2001 1079 1085
49. A.G. Ostermeyer, J.M. Paci, Y. Zeng, D.M. Lublin, S. Munro, and D.A. Brown Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets J. Cell Biol. 152 2001 1071 1078
50. A. Pol, R. Luetterforst, M. Lindsay, S. Heino, E. Ikonen, and R.G. Parton A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance J. Cell Biol. 152 2001 1057 1070
51. P. Liu, Y. Ying, Y. Zhao, D.I. Mundy, M. Zhu, and R.G. Anderson Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic J. Biol. Chem. 279 2004 3787 3792
52. D.L. Brasaemle, G. Dolios, L. Shapiro, and R. Wang Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes J. Biol. Chem. 279 2004 46835 46842
53. A. Pol, S. Martin, M.A. Fernandez, M. Ingelmo-Torres, C. Ferguson, C. Enrich, and R.G. Parton Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies Mol. Biol. Cell 16 2005 2091 2105
54. B.L. Trigatti, R.G. Anderson, and G.E. Gerber Identification of caveolin-1 as a fatty acid binding protein Biochem. Biophys. Res. Commun. 255 1999 34 39
55. S. Martin, and R.G. Parton Caveolin, cholesterol, and lipid bodies Semin. Cell Dev. Biol. 16 2005 163 174
56. A.W. Cohen, B. Razani, W. Schubert, T.M. Williams, X.B. Wang, P. Iyengar, D.L. Brasaemle, P.E. Scherer, and M.P. Lisanti Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation Diabetes 53 2004 1261 1270
57. P.G. Frank, H. Lee, D.S. Park, N.N. Tandon, P.E. Scherer, and M.P. Lisanti Genetic ablation of caveolin-1 confers protection against atherosclerosis Arterioscler. Thromb. Vasc. Biol. 24 2004 98 105
58. P.G. Frank, Y.L. Marcel, M.A. Connelly, D.M. Lublin, V. Franklin, D.L. Williams, and M.P. Lisanti Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I Biochemistry 41 2002 11931 11940
59. V. Mouraviev, L. Li, S.A. Tahir, G. Yang, T.M. Timme, A. Goltsov, C. Ren, T. Satoh, T.M. Wheeler, M.M. Ittmann, B.J. Miles, R.J. Amato, D. Kadmon, and T.C. Thompson The role of caveolin-1 in androgen insensitive prostate cancer J. Urol. 168 2002 1589 1596
60. S.E. Woodman, M.W. Cheung, M. Tarr, A.C. North, W. Schubert, G. Lagaud, C.B. Marks, R.G. Russell, G.S. Hassan, S.M. Factor, G.J. Christ, and M.P. Lisanti Urogenital alterations in aged male caveolin-1 knockout mice J. Urol. 171 2004 950 957
61. H.H. Lai, T.B. Boone, G. Yang, C.P. Smith, S. Kiss, T.C. Thompson, and G.T. Somogyi Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder Neurochem. Int. 45 2004 1185 1193
62. M.S. Goligorsky, H. Li, S. Brodsky, and J. Chen Relationships between caveolae and eNOS: everything in proximity and the proximity of everything Am. J. Physiol., Renal. Physiol. 283 2002 F1 F10
63. G. Garcia-Cardena, P. Oh, J. Liu, J.E. Schnitzer, and W.C. Sessa Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling Proc. Natl. Acad. Sci. U. S. A. 93 1996 6448 6453
64. P.W. Shaul, E.J. Smart, L.J. Robinson, Z. German, I.S. Yuhanna, Y. Ying, R.G. Anderson, and T. Michel Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae J. Biol. Chem. 271 1996 6518 6522
65. M. Bucci, J.P. Gratton, R.D. Rudic, L. Acevedo, F. Roviezzo, G. Cirino, and W.C. Sessa In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat. Med. 6 2000 1362 1367
66. J.B. Michel, O. Feron, D. Sacks, and T. Michel Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin J. Biol. Chem. 272 1997 15583 15586
67. E.M. Conway, D. Collen, and P. Carmeliet Molecular mechanisms of blood vessel growth Cardiovasc. Res. 49 2001 507 521
68. S. Esser, K. Wolburg, H. Wolburg, G. Breier, T. Kurzchalia, and W. Risau Vascular endothelial growth factor induces endothelial fenestrations in vitro J. Cell Biol. 140 1998 947 959
69. J. Liu, X.B. Wang, D.S. Park, and M.P. Lisanti Caveolin-1 expression enhances endothelial capillary tubule formation J. Biol. Chem. 277 2002 10661 10668
70. C. Griffoni, E. Spisni, S. Santi, M. Riccio, T. Guarnieri, and V. Tomasi Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo Biochem. Biophys. Res. Commun. 276 2000 756 761
71. S.E. Woodman, A.W. Ashton, W. Schubert, H. Lee, T.M. Williams, F.A. Medina, J.B. Wyckoff, T.P. Combs, and M.P. Lisanti Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli Am. J. Pathol. 162 2003 2059 2068
72. P. Sonveaux, P. Martinive, J. DeWever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J.L. Balligand, and O. Feron Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis Circ. Res. 95 2004 154 161
73. P.M. Bauer, J. Yu, Y. Chen, R. Hickey, P.N. Bernatchez, R. Looft-Wilson, Y. Huang, F. Giordano, R.V. Stan, and W.C. Sessa Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis Proc. Natl. Acad. Sci. U. S. A. 102 2005 204 209
74. W. Zundel, L.M. Swiersz, and A. Giaccia Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide Mol. Cell. Biol. 20 2000 1507 1514
75. A.W. Cohen, D.S. Park, S.E. Woodman, T.M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R.N. Kitsis, R.G. Russell, L.M. Weiss, B. Tang, L.A. Jelicks, S.M. Factor, V. Shtutin, H.B. Tanowitz, and M.P. Lisanti Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts Am. J. Physiol., Cell Physiol. 284 2003 C457 C474
76. F. Galbiati, D. Volonte, J.A. Engelman, G. Watanabe, R. Burk, R.G. Pestell, and M.P. Lisanti Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade EMBO J. 17 1998 6633 6648
77. J.A. Engelman, C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D.S. Kohtz, and M.P. Lisanti Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain FEBS Lett. 428 1998 205 211
78. P. Liu, Y. Ying, and R.G. Anderson Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae Proc. Natl. Acad. Sci. U. S. A. 94 1997 13666 13670
79. J.R. Glenney Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus J. Biol. Chem. 264 1989 20163 20166
80. A.J. Koleske, D. Baltimore, and M.P. Lisanti Reduction of caveolin and caveolae in oncogenically transformed cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 1381 1385
81. T.M. Williams, and M.P. Lisanti Caveolin-1 in oncogenic transformation, cancer, and metastasis Am. J. Physiol., Cell Physiol. 288 2005 C494 C506
82. K. Hayashi, S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi Invasion activating caveolin-1 mutation in human scirrhous breast cancers Cancer Res. 61 2001 2361 2364
83. F. Capozza, T.M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M.P. Lisanti Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation Am. J. Pathol. 162 2003 2029 2039
84. J.E. Maglione, D. Moghanaki, L.J. Young, C.K. Manner, L.G. Ellies, S.O. Joseph, B. Nicholson, R.D. Cardiff, and C.L. MacLeod Transgenic polyoma middle-T mice model premalignant mammary disease Cancer Res. 61 2001 8298 8305
85. T.M. Williams, M.W. Cheung, D.S. Park, B. Razani, A.W. Cohen, W.J. Muller, D. Di Vizio, N.G. Chopra, R.G. Pestell, and M.P. Lisanti Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice Mol. Biol. Cell 14 2003 1027 1042
86. T.M. Williams, F. Medina, I. Badano, R.B. Hazan, J. Hutchinson, W.J. Muller, N.G. Chopra, P.E. Scherer, R.G. Pestell, and M.P. Lisanti Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J. Biol. Chem. 279 2004 51630 51646
87. T.C. Thompson, T.L. Timme, L. Li, and A. Goltsov Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer Apoptosis 4 1999 233 237
88. T.M. Williams, G.S. Hassan, J. Li, A.W. Cohen, F. Medina, P.G. Frank, R.G. Pestell, D. Di Vizio, M. Loda, M.P. Lisanti, Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in TRAMP mice, J. Biol. Chem. (in press).
89. R. Sager, S. Sheng, A. Anisowicz, G. Sotiropoulou, Z. Zou, G. Stenman, K. Swisshelm, Z. Chen, M.J. Hendrix, and P. Pemberton RNA genetics of breast cancer: maspin as paradigm Cold Spring Harbor Symp. Quant. Biol. 59 1994 537 546
90. S.W. Lee, C.L. Reimer, P. Oh, D.B. Campbell, and J.E. Schnitzer Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells Oncogene 16 1998 1391 1397
91. J.A. Engelman, R.J. Lee, A. Karnezis, D.J. Bearss, M. Webster, P. Siegel, W.J. Muller, J.J. Windle, R.G. Pestell, and M.P. Lisanti Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer J. Biol. Chem. 273 1998 20448 20455
92. W. Zhang, B. Razani, Y. Altschuler, B. Bouzahzah, K.E. Mostov, R.G. Pestell, and M.P. Lisanti Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1 J. Biol. Chem. 275 2000 20717 20725
93. D.S. Park, H. Lee, C. Riedel, J. Hulit, P.E. Scherer, R.G. Pestell, and M.P. Lisanti Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism J. Biol. Chem. 276 2001 48389 48397
94. D.S. Park, H. Lee, P.G. Frank, B. Razani, A.V. Nguyen, A.F. Parlow, R.G. Russell, J. Hulit, R.G. Pestell, and M.P. Lisanti Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade Mol. Biol. Cell 13 2002 3416 3430
95. Z. Tang, P.E. Scherer, T. Okamoto, K. Song, C. Chu, D.S. Kohtz, I. Nishimoto, H.F. Lodish, and M.P. Lisanti Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle J. Biol. Chem. 271 1996 2255 2261
96. F. Galbiati, D. Volonte, J.B. Chu, M. Li, S.W. Fine, M. Fu, J. Bermudez, M. Pedemonte, K.M. Weidenheim, R.G. Pestell, C. Minetti, and M.P. Lisanti Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype Proc. Natl. Acad. Sci. U. S. A. 97 2000 9689 9694
97. C. Minetti, F. Sotgia, C. Bruno, P. Scartezzini, P. Broda, M. Bado, E. Masetti, M. Mazzocco, A. Egeo, M.A. Donati, D. Volonte, F. Galbiati, G. Cordone, F.D. Bricarelli, M.P. Lisanti, and F. Zara Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy Nat. Genet. 18 1998 365 368
98. F. Galbiati, D. Volonte, C. Minetti, D.B. Bregman, and M.P. Lisanti Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutant and rescues wild-type caveolin-3 J. Biol. Chem. 275 2000 37702 37711
99. F. Galbiati, D. Volonte, C. Minetti, J.B. Chu, and M.P. Lisanti Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex J. Biol. Chem. 274 1999 25632 25641
100. S.E. Woodman, F. Sotgia, F. Galbiati, C. Minetti, and M.P. Lisanti Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases Neurology 62 2004 538 543
101. F. Sotgia, G. Bonuccelli, C. Minetti, S.E. Woodman, F. Capozza, R.G. Kemp, P.E. Scherer, and M.P. Lisanti Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases Am. J. Pathol. 163 2003 2619 2634
102. F. Sotgia, S.E. Woodman, G. Bonuccelli, F. Capozza, C. Minetti, P.E. Scherer, and M.P. Lisanti Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease Am. J. Physiol., Cell Physiol. 285 2003 C1150 C1160
103. S. Repetto, M. Bado, P. Broda, G. Lucania, E. Masetti, F. Sotgia, I. Carbone, A. Pavan, E. Bonilla, G. Cordone, M.P. Lisanti, and C. Minetti Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy Biochem. Biophys. Res. Commun. 261 1999 547 550
104. P.L. Vaghy, J. Fang, W. Wu, and L.P. Vaghy Increased caveolin-3 levels in mdx mouse muscles FEBS Lett. 431 1998 125 127
105. K.S. Song, P.E. Scherer, Z. Tang, T. Okamoto, S. Li, M. Chafel, C. Chu, D.S. Kohtz, and M.P. Lisanti Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins J. Biol. Chem. 271 1996 15160 15165
106. S.E. Woodman, D.S. Park, A.W. Cohen, M.W. Cheung, M. Chandra, J. Shirani, B. Tang, L.A. Jelicks, R.N. Kitsis, G.J. Christ, S.M. Factor, H.B. Tanowitz, and M.P. Lisanti Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade J. Biol. Chem. 277 2002 38988 38997
107. B. Aravamudan, D. Volonte, R. Ramani, E. Gursoy, M.P. Lisanti, B. London, and F. Galbiati Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype Hum. Mol. Genet. 12 2003 2777 2788
108. Y. Ohsawa, H. Toko, M. Katsura, K. Morimoto, H. Yamada, Y. Ichikawa, T. Murakami, S. Ohkuma, I. Komuro, and Y. Sunada Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity Hum. Mol. Genet. 13 2004 151 157
109. H. Ishikawa Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation J. Cell Biol. 38 1968 51 66
110. R.G. Parton, M. Way, N. Zorzi, and E. Stang Caveolin-3 associates with developing T-tubules during muscle differentiation J. Cell Biol. 136 1997 137 154
111. D. Volonte, A.J. Peoples, and F. Galbiati Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C Mol. Biol. Cell 14 2003 4075 4088
112. C. Minetti, M. Bado, P. Broda, F. Sotgia, C. Bruno, F. Galbiati, D. Volonte, G. Lucania, A. Pavan, E. Bonilla, M.P. Lisanti, and G. Cordone Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency Am. J. Pathol. 160 2002 265 270
113. D.S. Park, S.E. Woodman, W. Schubert, A.W. Cohen, P.G. Frank, M. Chandra, J. Shirani, B. Razani, B. Tang, L.A. Jelicks, S.M. Factor, L.M. Weiss, H.B. Tanowitz, and M.P. Lisanti Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype Am. J. Pathol. 160 2002 2207 2217